once a week glp 1 Diabetes Patients Also Struggle to Access GLP-1 Agonists GLP-1 Injections for Medical Weight Discounted GLP-1 Weight Loss Drugs

Do not stop taking prescribed medications without medical advice

The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]

Regular consumption of bread enriched with lupine lowers BP, and lupine protein has been shown to reduce the risk of HTN and improve VF in rats

Supplementation is simply a way to provide the body with more of what it already creates